Although recurrent somatic mutations in the splicing factor U2AF1 (also known as U2AF35) have been identified in multiple cancer types. the effects of these mutations on the cancer transcriptome have yet to be fully elucidated. Here. we identified splicing alterations associated with U2AF1 mutations across distinct cancers using DNA and RNA sequencing data from The Cancer Genome Atlas... https://www.roneverhart.com/RKT-9-RDO/